It provides a comprehensive, end-to-end understanding of how new cancer therapies are conceived, tested, and brought into clinical practice for children.

This training is focused on clinical and translational oncology , with a specific lens on pediatric early-phase trials . The 2024 sessions were oriented around drug development, trial methodology, regulatory and safety considerations, and clinical application. Most relevant to pediatric oncologists, clinical research fellows, and translational scientists working directly within or alongside early-phase trial programs.

An overview of the 2024 programme, can be accessed via the link ITCC Training Days 2024 program FINAL_V3